Detalles de la búsqueda
1.
Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy.
J Virol
; 88(10): 5242-55, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24574403
2.
Fcγ receptor-mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies.
JCI Insight
; 7(19)2022 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35998045
3.
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system.
Cancer Res
; 67(18): 8847-55, 2007 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17875726
4.
Elevated IL-6/IL-1Ra ratio as a prognostic biomarker of poor chemotherapy efficacy in Chinese patients with metastatic NSCLC, validated in a Caucasian patient cohort.
Mol Clin Oncol
; 10(2): 309-317, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680213
5.
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-ßGal and MVA-MUC1 (TG4010) in a murine tumor model.
Hum Vaccin Immunother
; 14(1): 140-145, 2018 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28925793
6.
Chemical labels metabolically installed into the glycoconjugates of the target cell surface can be used to track lymphocyte/target cell interplay via trogocytosis: comparisons with lipophilic dyes and biotin.
Immunol Invest
; 36(5-6): 687-712, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18161525
7.
Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
Cancer Res
; 65(2): 641-9, 2005 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15695409
8.
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.
J Immunother Cancer
; 5(1): 70, 2017 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28923084
9.
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.
Vaccine
; 35(4): 577-585, 2017 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28012777
10.
Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer.
Mol Clin Oncol
; 6(2): 279-285, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28357111
11.
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.
Cancer Res
; 77(15): 4146-4157, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28536278
12.
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment.
Oncoimmunology
; 5(2): e1080414, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27057460
13.
Trial Watch-Oncolytic viruses and cancer therapy.
Oncoimmunology
; 5(2): e1117740, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27057469
14.
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition.
Oncoimmunology
; 5(10): e1220467, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853644
15.
Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand.
Oncoimmunology
; 4(5): e1003013, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155396
16.
Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins.
Transplantation
; 75(5): 657-62, 2003 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12640305
17.
Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein.
Clin Vaccine Immunol
; 21(2): 147-55, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24307238
18.
Trial Watch:: Oncolytic viruses for cancer therapy.
Oncoimmunology
; 3: e28694, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25097804
19.
Intravenous injection of MVA virus targets CD8+ lymphocytes to tumors to control tumor growth upon combinatorial treatment with a TLR9 agonist.
Cancer Immunol Res
; 2(12): 1163-74, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25168392
20.
Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
Arthritis Rheumatol
; 66(11): 2989-3000, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24623505